Frequencies for first 10,000 rows of lit_ref variable in demo2018q3 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,471 94.71 94.71 , AL?BATRAN S PERIOPERATIVE CHEMOTHER.. | 1 0.01 94.72 , ASAHINA H, OIZUMI S, YAMADA N, HARA.. | 2 0.02 94.74 , ASAHINA H, OIZUMI S, YAMADA N, HARA.. | 1 0.01 94.75 , AURRAN T, MAHE B, LETESTU R, NGUYEN.. | 1 0.01 94.76 , BERNIER C, JOSSELIN N, PEUVREL L, .. | 1 0.01 94.77 , BERNIER C, JOSSELIN N, PEUVREL L, .. | 1 0.01 94.78 , BERNIER C, JOSSELIN N, PEUVREL L, .. | 1 0.01 94.79 , BERNIER C, JOSSELIN N, PEUVREL L, .. | 3 0.03 94.82 , ESMAT G, FOUAD R, ALLAM N, HASSANY .. | 1 0.01 94.83 , FRIED M, REDDY R, SOLDEVILA?PICO C,.. | 1 0.01 94.84 , GOY A, FELDMAN T, RHODES J, LESLIE .. | 1 0.01 94.85 , INTRONE W, AKAL O, AKAL T, BARBU A,.. | 1 0.01 94.86 , INUI N, TANAKA K, YASUI H, HOZUMI H.. | 1 0.01 94.87 , KAKURAI K, SUZUKI H, ISHIZAKI E, KI.. | 1 0.01 94.88 , KAMPF S, LUTHKE K, ARINGER M RITUXI.. | 1 0.01 94.89 , KAPOOR S, VIJAYKUMAR S, GIDEA C, CA.. | 1 0.01 94.90 , KOBAYASHI Y, OGASAWARA S, ET AL. EX.. | 1 0.01 94.91 , KOIKE M, IWATA N, KANDA M, FUJIWARA.. | 1 0.01 94.92 , KRISTENSEN C, OVERGAARD M, RYTTER C.. | 1 0.01 94.93 , LEE K, YOON K, HONG S, LEE J, CHO J.. | 1 0.01 94.94 , MORSCHHAUSER F, CASASNOVAS O, MOLIN.. | 1 0.01 94.95 , NAKAO M, NAKAYAMA N, UCHIDA Y, ET A.. | 1 0.01 94.96 , NAKAYAMA N, UCHIDA Y, ET AL ORIGINA.. | 1 0.01 94.97 , OKAMOTO R, YOON S, SHIH L, ZHU J, L.. | 2 0.02 94.99 , OUCHI T, ITO H, SAWADA M, MUKAI M, .. | 1 0.01 95.00 , OZAWA K, TAKAGI S, ONODERA Y, YOKOY.. | 1 0.01 95.01 , SALEEM M AND AYTAC E POST PROCEDURE.. | 1 0.01 95.02 , SCALBERT C, LEPESANT P, DESMEDT E, .. | 2 0.02 95.04 , SCARPI E, PASSARDI A, NANNI O, PAGA.. | 1 0.01 95.05 , SCARPI E, PASSARDI A, NANNI O, PAGA.. | 2 0.02 95.07 , SEMBA H, FUJII S AND TSUMURA S RE?A.. | 1 0.01 95.08 , SHIMANOVICH I, LUDWIG R, ROSE C, ET.. | 1 0.01 95.09 , SPINA M, PESCE E, SALVI F, MERLI M,.. | 1 0.01 95.10 , STEDMAN C, HYLAND R, DING X, SVAROV.. | 1 0.01 95.11 , TANNA A, MCADOO S, MEDJERAL?THOMAS .. | 1 0.01 95.12 , WANG L, XU J, ZHANG R, YANG Y, HU.. | 1 0.01 95.13 , WARREN D, HURT C, AZNAR M, PARTRIDG.. | 1 0.01 95.14 ABEI M, YAMADA T, HASEGAWA, ET AL. EF.. | 1 0.01 95.15 ABEL BOENERJOUS R, ZIRKER W, MASILAMA.. | 1 0.01 95.16 ABRAMOWICZ M. IN BRIEF: SEVERE BRADYC.. | 1 0.01 95.17 ABRAMOWICZ M. IN BRIEF: SEVERE BRADYC.. | 1 0.01 95.18 ADACHI Y, ET AL.. A CASE OF LUNG ADEN.. | 1 0.01 95.19 AFOS, I.. POSTERIOR REVERSIBLE ENCEPH.. | 1 0.01 95.20 AGRAWAL V, CHAUDHARI S, SY A, DELATRE.. | 1 0.01 95.21 AIZU M, MIZUSHIMA I, NAKAZAKI S, NAKA.. | 1 0.01 95.22 AL?ALOUL M, MILLER H, STOCKTON P, LED.. | 1 0.01 95.23 AL?ALOUL, M.. ACUTE RENAL FAILURE IN .. | 1 0.01 95.24 AL?KHAZRAJI A, ALKHAWAM H, GARRIDO B... | 1 0.01 95.25 ALMORZA T, MUNOZ?HERNANDEZ M, LALUEZA.. | 1 0.01 95.26 ANG G, ZAYED H, SLAVOTINEK A AND RUTL.. | 1 0.01 95.27 ANG G, ZAYED H, SLAVOTINEK A AND RUTL.. | 1 0.01 95.28 ANTON N, FERNANDEZ?SEDAND L, GOMEZ?GA.. | 1 0.01 95.29 ASKLING J, FORED CM, BRANDT L, BAECKL.. | 3 0.03 95.32 AYA TAKAHASHI. EARLY NIGHT OF REVOLUT.. | 1 0.01 95.33 AZNAB, M.. STEVENS?JOHNSON SYNDROME P.. | 1 0.01 95.34 BACKUS, K.. TRICHOMONAS VAGINALIS TRE.. | 1 0.01 95.35 BALAGONI H, DEVANI K, PHEMISTER J, YO.. | 1 0.01 95.36 BANG, Y.. PHASE 3, RANDOMISED TRIAL O.. | 1 0.01 95.37 BANSAL N, MANOCHA D, MADHIRA B. LIFE?.. | 1 0.01 95.38 BARAKAT M, ALFISHAWY M, AHMED K, NATA.. | 1 0.01 95.39 BARAKAT, M.. A RARE CASE OF DRUG?INDU.. | 1 0.01 95.40 BEGON E, BENETON N, POIRAUD C, DROITC.. | 1 0.01 95.41 BENARD?LARIBIERE A, SALVO F, JEGOU MH.. | 1 0.01 95.42 BENE J, AUFFRET M, POTEY C, GAUTIER S.. | 1 0.01 95.43 BENNIS Y. MULTIPLE DRUGS INTERACTION .. | 1 0.01 95.44 BERLING I, MOSTAFA A, GRICE JE, ROBER.. | 1 0.01 95.45 BJORNSSON, E.. INCIDENCE, PRESENTATIO.. | 2 0.02 95.47 BLASCO MR, RAMOS A, MALO CG, MERINO A.. | 1 0.01 95.48 BOCCHETTA A. THYROID AND RENAL TUMORS.. | 1 0.01 95.49 BOCHOUARI, K.. BLEEDING INDUCED BY SE.. | 1 0.01 95.50 BOGGS J, BARNES L. DEMYELINATION DURI.. | 1 0.01 95.51 BONDA C, EVANS MS. METRONIDAZOLE CNS .. | 1 0.01 95.52 BOSANSKA L, SCHROEDER T, HOFF U, KOER.. | 1 0.01 95.53 BOUILLON A, BEIER F, FERREIRA MS, KER.. | 1 0.01 95.54 BRANDT C, ELSNER H, FURATSCH N, HOPPE.. | 1 0.01 95.55 BRUCHFELD A, BARANY P, HEDSTROM A AND.. | 1 0.01 95.56 BRUIJNINCKX CMA. FATAL PULMONARY EMBO.. | 1 0.01 95.57 BUCHHOLZ S, DAMMANN E, STADLER M, KRA.. | 1 0.01 95.58 BUYCK, H.. PRIOR IMMUNOSUPPRESSION TH.. | 1 0.01 95.59 CADEDDU, G.. CLOZAPINE TOXICITY DUE T.. | 1 0.01 95.60 CASTAIGNE, S.. EFFECT OF GEMTUZUMAB O.. | 1 0.01 95.61 CASTELNUOVO B, KIRAGGA A, MUSAAZI J, .. | 1 0.01 95.62 CHAE Y. POSTERIOR REVERSIBLE ENCEPHAL.. | 1 0.01 95.63 CHALOUHY C, CHALHOUB E, HAMMOUD D, LE.. | 1 0.01 95.64 CHAPUT F, AMER R, BAGLIVO E, TOUITOU .. | 1 0.01 95.65 CHIDAMBARA L, SINGHAL R, SRINIVASAN P.. | 1 0.01 95.66 CHIN J, FORZANI B, CHOWDHURY N, LOMBA.. | 1 0.01 95.67 CHUDOW, M.. A CASE OF SEVERE, REFRACT.. | 1 0.01 95.68 CLARK JI, BUFALINO S, SINGH S, BORYS .. | 1 0.01 95.69 COLLIDGE T.A.. SEVERE STATIN?INDUCED .. | 1 0.01 95.70 DANIEL A. UNDERSTANDING OF ANTIEPILEP.. | 1 0.01 95.71 DAVIES J, TIPPET R, WATSON AND METCAL.. | 1 0.01 95.72 DES ROCHES A., LE DEIST F., PARADIS J.. | 1 0.01 95.73 DESAI AV, LI Y, GETZ K, SEIF AE, FISH.. | 2 0.02 95.75 DESAI AV, LI Y, GETZ K, SEIF AE, FISH.. | 1 0.01 95.76 DESAI AV, LI Y, GETZ K, SEIF AE, FISH.. | 1 0.01 95.77 DESCOEUR J, PHILIBERT L, CHALARD K, A.. | 1 0.01 95.78 DI NUZZO, S... ARE ANTI?TNF?ALPHA AGE.. | 1 0.01 95.79 DIEM L, NEDELTCHEV K, KAHLES T, ACHTN.. | 1 0.01 95.80 DILLON, D.. ABUSE OF FENTANYL ANALGES.. | 1 0.01 95.81 DOI.ORG/10.1016/J.0000.2017.10.010 SC.. | 1 0.01 95.82 DOI.ORG/10.1016/J.JCMS.2018.05.046 AL.. | 1 0.01 95.83 DOI.ORG/10.1016/J.JCMS.2018.05.046 AL.. | 2 0.02 95.85 DOI: 10.1007/S12020?018?1699?9 POLYZO.. | 1 0.01 95.86 DOI: 10.1007/S13760?018?0996?7#. KOC .. | 1 0.01 95.87 DOI: 10.1111/1556?4029.12154#. GOTTZE.. | 1 0.01 95.88 DOI: 10.1136/ANNRHEUMDIS?2018?EULAR.4.. | 1 0.01 95.89 DONEDDU P, KAZMI M, SAMUEL M, MAHDI?R.. | 2 0.02 95.91 DRIOT, D.. PREGABALIN/NICOTINE ABUSE .. | 1 0.01 95.92 DURRIEU G, DARDONVILLE Q, MONTASTRUC .. | 1 0.01 95.93 D^ADAMO, D.. A PHASE II TRIAL OF SORA.. | 1 0.01 95.94 E K, F N, X X, F T, B K, M P, M S, E .. | 1 0.01 95.95 EL?SOLIA A, AL?OTAIBI K, AL?HWIESH A... | 1 0.01 95.96 ELDEM, I.. VENLAFAXINE INTOXICATION I.. | 1 0.01 95.97 ELLIOTT, S.. DETERMINING THE TOXICOLO.. | 1 0.01 95.98 ELLIOTT, S.. PREGABALIN TOXICITY: 9 C.. | 1 0.01 95.99 ELLIOTT, S.. PREGABALIN TOXICITY: 9 C.. | 1 0.01 96.00 ETCHEVERRIGARAY F, GRALL?BRONNEC M, .. | 1 0.01 96.01 F S, F N, V D, HA M, RA L. THROMBOTIC.. | 2 0.02 96.03 FAISSNER S, GOLD R. CLINICAL COMMENTA.. | 1 0.01 96.04 FEIN, DANIEL M., HAFEEZ ZOABE F., CAV.. | 1 0.01 96.05 FERRIS, M.. SUCCESSFUL RADIOFREQUENCY.. | 1 0.01 96.06 FLYNN, T.. CASE REPORT: SPIRONOLACTON.. | 1 0.01 96.07 FOLEY J, CARRILLO?INFANTE C, WENTEN M.. | 1 0.01 96.08 FONG PS, FLYNN DM, EVANS CD, KORTHUIS.. | 1 0.01 96.09 FUJIMI A, TAKAHASHI N, MIURA M, KANIS.. | 1 0.01 96.10 GABRIEL J, BALAGONI H, KAPILA A, BAJA.. | 1 0.01 96.11 GARCIA J. PROGRESSIVE MULTIFOCAL LEUK.. | 1 0.01 96.12 GARNIER A, EL MARABET EH, KWON T, PEU.. | 1 0.01 96.13 GBOLADE B A. ECTOPIC PREGNANCY WITH I.. | 1 0.01 96.14 GHIRINGHELLI F, VINCENT J, BELTJENS F.. | 1 0.01 96.15 GHIRINGHELLI F, VINCENT J, BELTJENS F.. | 2 0.02 96.17 GHIRINGHELLI, F.. FLUOROURACIL, LEUCO.. | 1 0.01 96.18 GHOLKAR, G.. THE HYBRID CHANNELOPATHY.. | 1 0.01 96.19 GOBBE P, SAUVEGARDE J, ROYEZ D. A 3.. | 1 0.01 96.20 GOLD R, MOTTE J, KNEIPHOF J, STRABBUR.. | 1 0.01 96.21 GOLD R, MOTTE J, KNEIPHOF J, STRABBUR.. | 1 0.01 96.22 GOLD R, MOTTE J, KNEIPHOF J, STRABBUR.. | 1 0.01 96.23 GOMEZ DE RUEDA F, GORDON SANTIAGO MM,.. | 1 0.01 96.24 GOTTZEIN A, MUSSHOFF F, MADEA B. SYST.. | 1 0.01 96.25 GRAY E, O^LEARY A, BERGIN C, CANNON M.. | 1 0.01 96.26 GRAY E, O^LEARY A, STEWART S, BERGIN .. | 1 0.01 96.27 GRAY E, O^LEARY A, STEWART S, BERGIN .. | 1 0.01 96.28 GRONEWALD A, DETTLING A, HAFFNER H, S.. | 1 0.01 96.29 GUDNASON HO, BJORNSSON HK, GARDARSDOT.. | 4 0.04 96.33 GUDNASON HO, BJORNSSON HK, GARDARSDOT.. | 1 0.01 96.34 GUPTA, N.. ACUTE RENAL FAILURE FOLLOW.. | 2 0.02 96.36 HAJIME YAMAZAKI ET AL,. A DISCUSSION .. | 1 0.01 96.37 HAKKINEN, M.. PROFILES OF PREGABALIN .. | 2 0.02 96.39 HAMA Y. EXACERBATION OF GEMCITABINE?R.. | 1 0.01 96.40 HAROON N, RAZA S, BHAT Z. HYPOMAGNESE.. | 1 0.01 96.41 HASIJA R. NEOPLASMS IN PEDIATRIC PATI.. | 1 0.01 96.42 HICKEY, P.. BOSUTINIB THERAPY RESULTI.. | 1 0.01 96.43 HIDEKI TAKAGI. A STUDY ON DISCONTINUA.. | 1 0.01 96.44 HIRANO T, KONAKA H, TAKAMATSU H, KUMA.. | 1 0.01 96.45 HIROYUKI M, OHGURO N, ITAYA H,YAWATA .. | 1 0.01 96.46 HODECKER S, STURNER K, BECKER V, ELIA.. | 1 0.01 96.47 HOELTZENBEIN M, ET AL.. RAMIPRIL/RIVA.. | 1 0.01 96.48 HOELTZENBEIN, M., ET AL. HOELTZENBEIN.. | 1 0.01 96.49 HOELTZENBEIN, M.. INCREASED RATE OF B.. | 1 0.01 96.50 HORIE S, NISHIDA H, SAKURAI T, ICHIYA.. | 1 0.01 96.51 HTTPS://DOI.ORG/10.1016/J.JCMS.2018.0.. | 1 0.01 96.52 HUNAULT?BERGER M, MAILLARD N, SCHMIDT.. | 1 0.01 96.53 HUNT, C.. TETRACYCLINE?INDUCED BILE D.. | 1 0.01 96.54 HYDZIK, P.. SIDE EFFECTS OF THE HMG?C.. | 1 0.01 96.55 IANNI, F.. GC?MS/MS DETECTS POTENTIA.. | 1 0.01 96.56 IBRAHEEM M, MARIN M, LEUNG J, BRYCE C.. | 1 0.01 96.57 IKEDA S, KATANO T, TABATA E, SHINTANI.. | 1 0.01 96.58 IMBULDENIYA, A.. BILATERAL ATYPICAL I.. | 1 0.01 96.59 INTERFERON?BETA 1A/METHYLPREDNISOLONE.. | 1 0.01 96.60 ISHIGAKI K, KATO I, MURAKAMI T, ET AL.. | 1 0.01 96.61 ISHIGAKI K, KATO I, MURAKAMI T, ET AL.. | 1 0.01 96.62 ISIDORO?GARCIA M, SANCHEZ?MARTIN A, G.. | 1 0.01 96.63 ITO T, NAKAYA A, FUJITA S, SATAKE A, .. | 1 0.01 96.64 ITO T, NAKAYA A, FUJITA S, SATAKE A, .. | 1 0.01 96.65 J.A. HUNTER. ACUTE PSYCHOSIS IN THREE.. | 1 0.01 96.66 JAFRI RZ, AL?RADADI R, BOUCHER?BERRY .. | 1 0.01 96.67 JOHAN L, ASTRID G, BRIGITTA L. LENALI.. | 1 0.01 96.68 JOHNSTON PB, LAPLANT B, MCPHAIL E, HA.. | 1 0.01 96.69 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 1 0.01 96.70 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 1 0.01 96.71 JOSEPH GABRIEL GABRIEL, VENKALASRIHAR.. | 1 0.01 96.72 JUTZELER, C.. JOURNAL CLUB: PREGNANCY.. | 1 0.01 96.73 JUTZELER, C.. JOURNAL CLUB: PREGNANCY.. | 1 0.01 96.74 K H. DEATH BY LEMONADE?. ANASTHESIOL?.. | 1 0.01 96.75 K L. | 1 0.01 96.76 KAMIO T, KAWANO S, ONISHI H, OBAYASHI.. | 1 0.01 96.77 KAMOURICH S, GANANANDAN K, RAFFEL J, .. | 1 0.01 96.78 KANG M, GUPTA R, DAWISKIBA M, PINCUS .. | 1 0.01 96.79 KANG M, GUPTA R, DAWISKIBA M, PINCUS .. | 1 0.01 96.80 KANG M, GUPTA R, SRINIVASAN J. PERIPH.. | 2 0.02 96.82 KANG M. PERIPHERAL VASCULITIC NEUROPA.. | 1 0.01 96.83 KANG M. PERIPHERAL VASCULITIC NEUROPA.. | 1 0.01 96.84 KANG MK, GUPTA RK, SRINIVASAN J. PERI.. | 1 0.01 96.85 KANG MK, GUPTA RK, SRINIVASAN J. PERI.. | 1 0.01 96.86 KANO K, KATAYAMA T, TAKEGUCHI S, ASAN.. | 1 0.01 96.87 KANO K, KATAYAMA T, TAKEGUCHI S, ASAN.. | 1 0.01 96.88 KARAJAMAKI A, LAURI T AND EBELING T.... | 1 0.01 96.89 KARAJAMAKI, LAURI T, EBELING T. ANTIP.. | 1 0.01 96.90 KARAJAMAKI, LAURI T, EBELING T. ANTIP.. | 1 0.01 96.91 KARVELLAS C, CARDOSO F, GOTTFRIED M, .. | 1 0.01 96.92 KARVELLAS C, CARDOSO F, GOTTFRIED M, .. | 1 0.01 96.93 KATAYAMA K, KUMAGAI R, ISONO M, FUJIH.. | 1 0.01 96.94 KATSURAGI T, IWASHIGE A, TSUKADA J. I.. | 1 0.01 96.95 KHALID M, FAKHRAN S, BHALERAO N, SALE.. | 1 0.01 96.96 KHOBRANI MA, DUDLEY SW, HUCKLEBERRY Y.. | 1 0.01 96.97 KIKUCHI S, FUJITA Y, ONODERA M, FUJIN.. | 1 0.01 96.98 KIM JS, KIM DJ, YOU T, JEON JY. DE NO.. | 1 0.01 96.99 KIMURA Y, GREVICH S, BEUKELMAN T, MOR.. | 1 0.01 97.00 KINTZ, P.. ASSESSMENT OF PREGABALIN U.. | 2 0.02 97.02 KISHIBE M, YAMAMOTO A, KOBAYASHI A, K.. | 1 0.01 97.03 KOLA M, HACIOGLU D, ERDOL H, TURK A. .. | 1 0.01 97.04 KOUDELKOV M, SZABOVA Z, HAVRDOVA E, P.. | 1 0.01 97.05 KOVACH JL. GEMCITABINE?INDUCED RETINO.. | 1 0.01 97.06 KRISTIAN R, STEFANIE B, BERNHARD K, M.. | 1 0.01 97.07 KRONBICHLER A, LUGER A, LOACKER L, PI.. | 1 0.01 97.08 KUROKAWA, M.. DRUG?INDUCED HYPERSENSI.. | 1 0.01 97.09 KURSUN H, DIEHL C, GELDNER G. DEATH .. | 1 0.01 97.10 KURTZHALTS K, GEE ME, FEUZ L, KRAJEWS.. | 1 0.01 97.11 KUSTERMANN A, MOBIUS C, OBERSTEIN T, .. | 1 0.01 97.12 LAAKE, A.. TUBERCULOSIS REACTIVATION .. | 1 0.01 97.13 LADHA A,ALAM A, IDESTRUP C, SAWYER J,.. | 1 0.01 97.14 LAZZERI L. CICLOSPORIN/IMATINIB/PREDN.. | 1 0.01 97.15 LEBRUN J, ET AL. BRENTUXIMAB AND CYTO.. | 1 0.01 97.16 LEDUCQ S, MEURISSE V, ZARAGOZA F, PRE.. | 1 0.01 97.17 LEE B,BRAEHLER M. USE OF TEST DOSE AL.. | 1 0.01 97.18 LEE LE, BLYTH DM, BARSOUMIAN AE, RAJ .. | 2 0.02 97.20 LELONG J, VENISSE N, BRUNET B, MURA P.. | 1 0.01 97.21 LELONG J, VENISSE N, HOUPERT T, BRUNE.. | 1 0.01 97.22 LIBBRECHT, C.. GH INJECTION?SITE SARC.. | 1 0.01 97.23 LITERATURE REFERENCE: WELCH TL, PASTE.. | 1 0.01 97.24 LO SCHIAVO, A.. PEMPHIGUS ERYTHEMATOS.. | 1 0.01 97.25 LOCHHEAD J. SSRI?ASSOCIATED OPTIC NEU.. | 1 0.01 97.26 LOEWENSTEIN D, KHONG T. A CASE OF MON.. | 1 0.01 97.27 LUND J, GRUBER A, BLIMARK C, LAURI B,.. | 1 0.01 97.28 LUND J, GRUBERT A, LAURI B. LENALIDOM.. | 1 0.01 97.29 LUOTIO K, MATTILA M AND KOTILAINEN R .. | 1 0.01 97.30 LYMPEROPOULOS E. ELECTROLYTE DISORDER.. | 1 0.01 97.31 MAEBA H, NISHIMURA Y, UMASE S, FUJIKI.. | 1 0.01 97.32 MAHADEVAN, U.. OUTCOMES OF PREGNANCIE.. | 2 0.02 97.34 MAHE J, DELBOVE A, VEYRAC G, JOYAU C,.. | 1 0.01 97.35 MAMELI A, CIANCHETTI M, RUBERTO F, MU.. | 1 0.01 97.36 MANCANO, M.. ISMP ADVERSE DRUG REACTI.. | 1 0.01 97.37 MANNING, D.. A TALE OF UNEQUAL SUBSTI.. | 1 0.01 97.38 MARSCHNER N, UNKNOWN, SALAT C, SOLING.. | 1 0.01 97.39 MARTIN?NAVARRO, J.. ACUTE RENAL FAILU.. | 1 0.01 97.40 MASATOMO ISHIOH. PSEUDOGOUT ATTACK AF.. | 1 0.01 97.41 MASCHERONA I, POLI M. HYPERKALAEMIA I.. | 1 0.01 97.42 MASSEY T, SMITH R, SADIQ S, OVERTON C.. | 1 0.01 97.43 MATSUMOTO D.ET AL.,. BRONCHIAL OCCLUS.. | 1 0.01 97.44 MAYUMI TANI. P3?177 EVALUATION OF SKI.. | 1 0.01 97.45 MCGRANE IR, SHUMAN MD, MCDONALD RW. D.. | 1 0.01 97.46 METAXAS EL, KOTSIFAS K, TATSIS G, HAZ.. | 1 0.01 97.47 MICHAELS G,KOCHANEK M,PFISTER R. LIFE.. | 1 0.01 97.48 MIKLAVCIC P, AVCIN S, JAZBEC J, VIPOT.. | 1 0.01 97.49 MILLER KD, NEIL AO, DANG C, NORTHFELT.. | 1 0.01 97.50 MILTGEN G., PAILLOT J., VANLEMMENS C... | 1 0.01 97.51 MIMA, A.. METHOTREXATE INDUCED PNEUMA.. | 1 0.01 97.52 MIURA M, IWATSUKA TAKUYA, GOTO HIROSH.. | 1 0.01 97.53 MIURA M, MASAHIRO MIRU AT AL. UNKNOWN.. | 1 0.01 97.54 MIYAHARA E, ITAGAKI T, KUWAHARA M, KA.. | 1 0.01 97.55 MIYAKE N. ADVERSE EVENTS OF LENVATINI.. | 1 0.01 97.56 MIYAKE N. ADVERSE EVENTS OF LENVATINI.. | 1 0.01 97.57 MIYAZAKI Y. A CASE OF PATIENT PRESENT.. | 1 0.01 97.58 MOELLENTIN, D.. CASE STUDY OF FATAL S.. | 1 0.01 97.59 MOISSEIEV E, MORSE LS FLUOCINOLONE AC.. | 1 0.01 97.60 MORAN M. REVERSIBLE EXACERBATION OF O.. | 1 0.01 97.61 MORISHITA M, ENDO T, BABA T, KUNO Y, .. | 1 0.01 97.62 MORISHITA M, ENDO T, BABA T, KUNO Y, .. | 1 0.01 97.63 MORISHITA M, ENDO T, MIZUUCHI M, KUNO.. | 1 0.01 97.64 MORISHITA M, ENDO T, MIZUUCHI M, KUNO.. | 1 0.01 97.65 MORISHITA M, ENDO T, MIZUUCHI M, KUNO.. | 1 0.01 97.66 MORISHITA M, ENDO T, MIZUUCHI M, KUNO.. | 1 0.01 97.67 MORITA Y, ET AL.. P?S?127 DRUG?INDUCE.. | 1 0.01 97.68 MORITA, R.. EFFECTIVENESS OF PERIODIC.. | 1 0.01 97.69 MOSICH V, MULLER?BUSCH HC. SUICIDAL D.. | 1 0.01 97.70 MOTA, I.? GASPAR, A.? CHAMBEL, M.? MO.. | 1 0.01 97.71 MOTOYAMA M, KOUNO H. RECURRING GASTRO.. | 1 0.01 97.72 MOTTE J, KNEIPHOF J, STRASSBURGER?KRO.. | 1 0.01 97.73 MOTTE J, KNEIPHOF J, STRASSBURGER?KRO.. | 1 0.01 97.74 MOWRY, J.. 2015 ANNUAL REPORT OF THE .. | 1 0.01 97.75 MUNHOZ R, PEREIRA A,TROQUES C,FEHER O.. | 1 0.01 97.76 MURAOKA Y, ET AL. A CASE OF DRUG?INDU.. | 1 0.01 97.77 M^KADA H, PERAZZO H, MUNTEANU M, NGO.. | 1 0.01 97.78 M^KADA H, PERAZZO H, MUNTEANU M, NGO .. | 1 0.01 97.79 N ALBINUS. FEJLDOSERING AF GIGTMIDDEL.. | 1 0.01 97.80 NAGATA K, INABA T, KINOSHITA S. CD5?P.. | 1 0.01 97.81 NAGATA, Y.. SUCCESSFUL TREATMENT OF A.. | 1 0.01 97.82 NAKAGAWA M, NAKANO H, NOMURA S, ET AL.. | 1 0.01 97.83 NAKAMURA K. A..CASE OF STAGE 4 RECTAL.. | 1 0.01 97.84 NAKANO K, KASHIWAMURA H, MUNAKATA A, .. | 1 0.01 97.85 NAKATA E. A STUDY OF THE INCIDENCE OF.. | 1 0.01 97.86 NGUYEN PVQ, SPINELLI C. PRESCRIBING C.. | 1 0.01 97.87 NGUYEN, P.. PRESCRIBING CASCADE IN AN.. | 1 0.01 97.88 NISHIKAWA, T.. IATROGENIC ADRENAL SUP.. | 1 0.01 97.89 NISHIOKA S. A CASE OF BILATERAL ATYPI.. | 1 0.01 97.90 NISHIOKA S. A CASE OF BILATERAL ATYPI.. | 1 0.01 97.91 NISSEN SE, YEOMANS ND, SOLOMON DH, LU.. | 3 0.03 97.94 NIWA, M.. FOUR CASES OF CEFTRIAXONE?A.. | 1 0.01 97.95 NOESSLINGER T. | 1 0.01 97.96 NOGUEIRA, A.. DRUG?INDUCED LUPUS?A DI.. | 1 0.01 97.97 NOORANI, I.. PHENYTOIN?INDUCED METHAE.. | 1 0.01 97.98 NORIKO SHUZENJI, ET AL.. A CASE OF LI.. | 1 0.01 97.99 NOSE K, ET AL.. CLINICAL EXPERIENCE W.. | 1 0.01 98.00 NOVITSKAYA E, CATES C, BOWES O, VIVIA.. | 1 0.01 98.01 NOVITSKAYA E, CATES C, BOWES O, VIVIA.. | 1 0.01 98.02 NOVITSKAYA E, CATES C, BOWES O, VIVIA.. | 1 0.01 98.03 NOVITSKAYA ES, CATES CA, BOWES OM, VI.. | 1 0.01 98.04 NYKIEL J, CARINO G, LEVINSON A. LITHI.. | 1 0.01 98.05 OKLAND, T.. A CASE OF AGGRESSIVE PSYC.. | 1 0.01 98.06 ONG, M.. ANTITUMOR ACTIVITY OF NIVOLU.. | 1 0.01 98.07 OTA T, FUJII H, MORITA R, MATSUMOTO J.. | 1 0.01 98.08 PAECH, C.. THE BLUE CHILD ? AMIODARON.. | 1 0.01 98.09 PAPAROUPA M, PIETRZAK S, GILLISSEN A... | 1 0.01 98.10 PAPAROUPA M. ACUTE RHABDOMYOLYSIS ASS.. | 1 0.01 98.11 PAULKE A, WUNDER C, TOENNES SW. SLEEP.. | 1 0.01 98.12 PAULKE, A.. SLEEP SELF?INTOXICATION A.. | 1 0.01 98.13 PELES E, LINZY S, SASON A, ADELSON M... | 1 0.01 98.14 PICIUCCHI S, GURIOLI C, BARONE D, GUR.. | 1 0.01 98.15 PILGRIM, J.. DEATHS INVOLVING MDMA AN.. | 6 0.06 98.21 PIZZOGLIO V., BEAU?SALINAS F., PINEL .. | 1 0.01 98.22 POLIS, C.. PREFERENCE FOR SAYANA PRES.. | 1 0.01 98.23 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 98.24 PONZETTI, A.. JAW OSTEONECROSIS ASSOC.. | 1 0.01 98.25 PORCARO F, DI MARCO A, CUTRERA R. OMA.. | 1 0.01 98.26 PRIVACY P. UNKNOWN. UNKNOWN ?:?. | 1 0.01 98.27 PRIVACY, BERNIER C, JOSSELIN N, PEUV.. | 1 0.01 98.28 PRIVACY, GONDOUIN A, VALNET RABIER M,.. | 1 0.01 98.29 PROTIC D.. A CASE OF MYOSITIS WITH IM.. | 1 0.01 98.30 PUIG?COMAS G, GARCIA PELAEZ M, GORGAS.. | 1 0.01 98.31 PUNGPAPONG S, LIESE MD, WATT KD, VARG.. | 1 0.01 98.32 RABAH, F.. AMLODIPINE: THE DOUBLE EDG.. | 2 0.02 98.34 RACHOW T, DORNAUS S, SAYER HG, HERMAN.. | 1 0.01 98.35 RAFFEL J, GAFSON A, MALIK O, NICHOLAS.. | 1 0.01 98.36 RAFFEL J. ANTI?JC VIRUS ANTIBODY TITR.. | 1 0.01 98.37 RAKOTONARIVO L, LONS?DANIC D, JANIER .. | 1 0.01 98.38 REPORTER KNOWN TO COMPANY, MIKETIC N .. | 1 0.01 98.39 RIBEIRO BAPTISTA B, PETITPAIN N, GOME.. | 1 0.01 98.40 RICHEBE P, BAILLY F, MARIANI L, PENA .. | 1 0.01 98.41 RIZKALLAH, J.. THE USE OF DRONEDARONE.. | 1 0.01 98.42 ROCCHI F, BAIARDI P, BARBIERI I, DEL .. | 1 0.01 98.43 ROCCHI F, BAIARDI P, BARBIERI I, DEL .. | 3 0.03 98.46 ROCCHI F, BAIARDI P, BARBIERI I, DEL .. | 1 0.01 98.47 ROGERS P,PAN W,DRACHTMAN R,HAINES C. .. | 1 0.01 98.48 ROGERS, P.. A STROKE MIMIC: METHOTREX.. | 1 0.01 98.49 ROY S, GANDHI AK, JANA M, JULKA PK. R.. | 1 0.01 98.50 RUSSELL JAMES A.. DURABLE EVENT?FREE .. | 1 0.01 98.51 S. TAKASHIMA., T. NARITA., H. OTOMO.,.. | 1 0.01 98.52 SAKAI T. A PATIENT WHO HAD RAPID CRIS.. | 1 0.01 98.53 SAMMUT L, WALLIS D, HOLROYD C. PROGRE.. | 1 0.01 98.54 SANO T, RYUHEI U, HISASHI U. PRACTICA.. | 1 0.01 98.55 SARAYA T, FUKUOKA K, MARUNO H, KOMAG.. | 1 0.01 98.56 SASAKI R, MOCHIDA K, KOKETSU H, WATAN.. | 1 0.01 98.57 SATO T, ET AL.. A CASE OF DIFFUSE WAL.. | 1 0.01 98.58 SATO T, KAWASAKI Y, ITO A, IZUMI H, K.. | 1 0.01 98.59 SCHARL, A.. FATIGUE FOLLOWING ONCOLOG.. | 1 0.01 98.60 SCHIESSI B, SCHNELDER K, ZIMMERMANN A.. | 1 0.01 98.61 SCHILTZ B, PAYNE E, GLEICH S, OUELLET.. | 1 0.01 98.62 SCIBELLI S, CESARI E, CARNOVALE C, GE.. | 1 0.01 98.63 SEARS, S.. INCIDENCE OF SUSTAINED VEN.. | 1 0.01 98.64 SEIKO MITUSI. POSSIBLE MACROPHAGE ACT.. | 1 0.01 98.65 SERRET CA, WANG S, MARSCH A, HERNANDE.. | 1 0.01 98.66 SHAH AP, CAMERON A, SINGH P, FRANK .. | 1 0.01 98.67 SHAH, M.A.. ANDECALIXIMAB/GS?5745 ALO.. | 1 0.01 98.68 SHAJAHAN P, CORDINER M, MCAVOY S, BAS.. | 1 0.01 98.69 SHAKUR R, KALER MK, HOWARD R.. QUETIA.. | 1 0.01 98.70 SHEBAK S, VARMA A. LOW TESTOSTERONE L.. | 1 0.01 98.71 SHERER, J.. DIPHENHYDRAMINE FOR ACUTE.. | 1 0.01 98.72 SHIBUYA J, ISHIKI YOSHITO AND HANDA M.. | 1 0.01 98.73 SHIDA G. A NEUTROPHIL EXTRACELLULAR T.. | 1 0.01 98.74 SHINOHARA, SATOSHI. CARDIAC ARREST DU.. | 1 0.01 98.75 SHOKO A, KOSUKE K, YUKI M, TADAHIRO N.. | 1 0.01 98.76 SIDDIQUE O, RASLA S, CLARK S AND KOKK.. | 1 0.01 98.77 SIGNORELLI F, NOGUEIRA A, DOMINGUES V.. | 1 0.01 98.78 SIGNORELLI F, NOGUEIRA F, DOMINGUES V.. | 1 0.01 98.79 SIGNORELLI F, NOGUEIRA F, DOMINGUES V.. | 1 0.01 98.80 SIGNORELLI F, NOGUEIRA F, DOMINGUES V.. | 1 0.01 98.81 SIGNORELLI F, NOGUEIRA F, MARIZ HA, L.. | 1 0.01 98.82 SIGNORELLI F, NOGUERIA F, DOMINGUES V.. | 1 0.01 98.83 SIGNORELLI M, COSTANZO M, CINCONZE M,.. | 1 0.01 98.84 SIGNORELLI M, COSTANZO M, CINCONZE M,.. | 1 0.01 98.85 SINCLAIR S, JONES J, MILLER R, GREENE.. | 5 0.05 98.90 SKARET MM, KWOK ML, SINGLA MB, ARMBRU.. | 1 0.01 98.91 SLATTER MA, ENGELHARDT KR, BURROUGHS .. | 1 0.01 98.92 SOBRERO A, LONARDI S, ROSATI G, DI B,.. | 1 0.01 98.93 SOGBANMU OO, ADENIYI OV, FUENTES YO, .. | 1 0.01 98.94 SON, R.. DESIRE FOR PREGNANCY IN THE .. | 1 0.01 98.95 SOUKALOVA J, VEJMELKOVA K, CERMANOVA .. | 1 0.01 98.96 SPUSTOVA V.? ROSENBERGER J.? LAJDOVA .. | 3 0.03 98.99 STOREK J, LECLERCQ S AND AARON S LACK.. | 1 0.01 99.00 STOREK J, LECLERCQ S, AARON S. LACK O.. | 1 0.01 99.01 STRENGER V, MERTH G, LACKNER H, ABERL.. | 1 0.01 99.02 STRUYE A, DEPUYDT C, SATER EA, DUBOI.. | 1 0.01 99.03 SU P?YP, MILLER S, RUTISHAUSER RL, BA.. | 1 0.01 99.04 SUGAWARA, Y.. ACUTE ENCEPHALOPATHY DE.. | 3 0.03 99.07 SULE EA.. T2 BREAST CANCER PRESENTING.. | 1 0.01 99.08 SUZUKI H. ET AL.. II?P?104 TWO AGED D.. | 1 0.01 99.09 SUZUKI S. INVESTIGATION ON CASES TREA.. | 1 0.01 99.10 SUZUKI, E.. METHOTREXATE?ASSOCIATED L.. | 1 0.01 99.11 SYSTEMIC MASTOCYTOSIS IDENTIFIED IN T.. | 1 0.01 99.12 TAGUCHI T, MITSUDA T, MATSUI T, ET AL.. | 1 0.01 99.13 TAHATA S, SAGARA T, KAWATANI Y. TREA.. | 1 0.01 99.14 TAKACS, R.. CATATONIA IN DISULFIRAM I.. | 1 0.01 99.15 TAKADA T. ROLE OF IL?15 IN INTERSTITI.. | 1 0.01 99.16 TAKAHASHI J, KUMAKURA M, OKAWA M, TOM.. | 1 0.01 99.17 TAKAHIRO OSAWA, KEIJI SUGISHITA, MASA.. | 1 0.01 99.18 TAKAYOSHI K, ASUKA A, HIDEYUKI O, TOM.. | 1 0.01 99.19 TANAKA T, KUZUYA T, YAMAMOTO K, ANDO .. | 1 0.01 99.20 TANAKA, K. THE EFFECTS OF MITIGLINIDE.. | 1 0.01 99.21 TANAKA, Y.. TOFACITINIB (CP?690,550),.. | 1 0.01 99.22 TANAKA,K. THE EFFECTS OF MITIGLINIDE .. | 1 0.01 99.23 TANG X, SONG YH, SUN A, ZHU X, RUAN C.. | 1 0.01 99.24 TARAO K. P2?2 TWO CASES OF PATIENTS W.. | 1 0.01 99.25 TASOGLU O, GOKCAN H, DEMIR SO, YENIGU.. | 1 0.01 99.26 TASOGLU O, GOKCAN H, OZBUDAK SD, YENI.. | 1 0.01 99.27 TAYLOR JL. BUPRENORPHINE/OXYCODONE/PA.. | 1 0.01 99.28 THOMAS A, RAJAN A, KHOZIN S, SZABO E,.. | 1 0.01 99.29 THORBORG C, HORN EP, MOFID H, LANGER .. | 1 0.01 99.30 THRONTON SL, CLARK RF. ENCEPHALOPATHY.. | 1 0.01 99.31 TOCE M, BURNS M. METHADONE?INDUCED HY.. | 1 0.01 99.32 TOQUET, S.. SEVERE APOPTOTIC ENTEROPA.. | 1 0.01 99.33 TORI M, SHIMO T. LONG?TERM EFFICACY O.. | 1 0.01 99.34 TOUZEAU C, MOREAU P. HOW I TREAT EXTR.. | 1 0.01 99.35 TREMBLAY F, CHAPDELAINE H, LAVOIE A, .. | 1 0.01 99.36 TSO G, KOLUR U. QUETIAPINE?INDUCED CE.. | 1 0.01 99.37 TSUKAZAKI Y. IATROGENIC IMMUNODEFICIE.. | 1 0.01 99.38 TSUZUKI M, INAGUMA Y, HANDA K, HASEGA.. | 1 0.01 99.39 UBE K, ET AL. A CASE OF LUNG ADENOCAR.. | 1 0.01 99.40 UNKNOWN U, TAN C, YAP K. TAMSULOSIN?I.. | 1 0.01 99.41 UPADHYAY KJ, PARMAR SJ, PARIKH RP, GA.. | 1 0.01 99.42 VALENTIN, B.. VINCRISTINE/VORICONAZOL.. | 1 0.01 99.43 VALLERSNES. ADOLESCENT WITH RESPIRATO.. | 1 0.01 99.44 VAN DER HEIJDE D. TOFACITINIB, AN ORA.. | 1 0.01 99.45 VAN ZWEEDEN, A.. RANDOMIZED PHASE 2 S.. | 1 0.01 99.46 VAN ZWEEDEN, A.. RANDOMIZED PHASE 2 S.. | 1 0.01 99.47 VANDAMME M, PAUWELS W, BLEECKER J. A .. | 1 0.01 99.48 VEREA MM, DEL POZO J, YEBRA?PIMENTEL .. | 1 0.01 99.49 VESELINOVIC T, SCHORN H, VERNALEKEN I.. | 1 0.01 99.50 VINCENT L, BRET C, VILLALBA M, SANO.. | 1 0.01 99.51 VOLKOV A.V., YUDKINA N.N., NIKOLAEVA .. | 1 0.01 99.52 WALKER, G.. AN UNUSUAL CASE OF RABIES.. | 1 0.01 99.53 WALSHAW M, ALOUL M, MILLER H, STOCKTO.. | 1 0.01 99.54 WALTON, J? BYRUM, M? SHUMAKER, A, COU.. | 1 0.01 99.55 WAN ZAIDI, W.. RITUXIMAB?INDUCED LUNG.. | 2 0.02 99.57 WARNKE C. THE CSF JCV ANTIBODY INDEX .. | 1 0.01 99.58 WATANABE M, TAKASHINA T, ASAHINA H, A.. | 1 0.01 99.59 WATANABE S ET AL.. A CASE OF DASATINI.. | 1 0.01 99.60 WILLIAMS G, GANDHI S, ALTAMIRANO A. A.. | 1 0.01 99.61 WONG J, KUZEL P, MULLEN J, LIEN D, MA.. | 1 0.01 99.62 WOODCOCK, H.. BURKITT^S NON?HODGKINS .. | 1 0.01 99.63 YABE, S.. A SURGERY OF SMALL INTESTIN.. | 1 0.01 99.64 YABUKI K, SHIBA E, HARADA H, UCHIHASH.. | 1 0.01 99.65 YAGNIK B. DRUG SAFETY : ADVERSE REACT.. | 1 0.01 99.66 YAMAMOTO, T.. A CASE OF ASCENDING COL.. | 1 0.01 99.67 YAMANAKA H. THREE?YEAR SAFETY AND TWO.. | 2 0.02 99.69 YAMANAKA H. THREE?YEAR SAFETY AND TWO.. | 1 0.01 99.70 YAMANAKA, H.. THREE?YEAR SAFETY AND T.. | 2 0.02 99.72 YAMANAKA, H.. TOFACITINIB (CP?690,550.. | 5 0.05 99.77 YAMANAKA, H.. TOFACITINIB (CP?690,550.. | 1 0.01 99.78 YAMAZAKI, K.? YAMASHITA, K.? KUSHIMA,.. | 2 0.02 99.80 YAMAZAKI, K.? YAMASHITA, K.? KUSHIMA,.. | 1 0.01 99.81 YAMAZAKI, K.? YAMASHITA, K.? NAKANISH.. | 1 0.01 99.82 YANG IF, HWANG JL, CHEN HJ, HUANG LW... | 1 0.01 99.83 YASUHIRO TOYODA. USE OF PEGFILGRASTIM.. | 1 0.01 99.84 YASUI H, ARAI T, HAMAGUCHI T, SHIRAO .. | 1 0.01 99.85 YOSHIDA Y, AISU N, KOJIMA D, MERA T, .. | 1 0.01 99.86 YU, A.. OCCUPATIONAL AIRBORNE CONTACT.. | 1 0.01 99.87 YUMIBA S, KOMORI K, IWANISHI T, KOID.. | 3 0.03 99.90 YUSTE J R, BERTO J, DEL POZO J L, LEI.. | 1 0.01 99.91 YUZHOU S.. ANALYSIS ON ADVERSE REACTI.. | 1 0.01 99.92 ZABRON A, PEDDU P, LEWIS D, HENEGHAN .. | 1 0.01 99.93 ZABRON A, PEDDU P, LEWIS D, HENEGHAN .. | 1 0.01 99.94 ZAFFANELLO M, BRUGNARA M, ANGELI S, C.. | 1 0.01 99.95 ZALESKI K., GORSKA A., KOLODZIEJ M., .. | 1 0.01 99.96 ZANCHELLI, F.. ATYPICAL HEMOLYTIC URE.. | 1 0.01 99.97 ZHANG Y, WRIGHT C, FLORES A. ASYMPTOM.. | 1 0.01 99.98 ZHU C, LI D, XIONG F, ZHU Y, SONG L A.. | 1 0.01 99.99 ZUR NIEDEN T, CONRAD T.. FEMALE PATIE.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 7 Mar 2019